Your browser doesn't support javascript.
loading
CD20-Targeted Therapy Ablates De Novo Antibody Response to Vaccination but Spares Preestablished Immunity.
Shree, Tanaya; Shankar, Vishnu; Lohmeyer, Julian J K; Czerwinski, Debra K; Schroers-Martin, Joseph G; Rodriguez, Gladys M; Beygi, Sara; Kanegai, Alyssa M; Corbelli, Karen S; Gabriel, Etelka; Kurtz, David M; Khodadoust, Michael S; Gupta, Neel K; Maeda, Lauren S; Advani, Ranjana H; Alizadeh, Ash A; Levy, Ronald.
  • Shree T; Division of Oncology, Department of Medicine, Stanford University, Stanford, California.
  • Shankar V; Program in Immunology, Stanford University School of Medicine, Stanford, California.
  • Lohmeyer JJK; Division of Oncology, Department of Medicine, Stanford University, Stanford, California.
  • Czerwinski DK; Division of Oncology, Department of Medicine, Stanford University, Stanford, California.
  • Schroers-Martin JG; Division of Oncology, Department of Medicine, Stanford University, Stanford, California.
  • Rodriguez GM; Division of Oncology, Department of Medicine, Stanford University, Stanford, California.
  • Beygi S; Division of Oncology, Department of Medicine, Stanford University, Stanford, California.
  • Kanegai AM; Division of Oncology, Department of Medicine, Stanford University, Stanford, California.
  • Corbelli KS; Division of Oncology, Department of Medicine, Stanford University, Stanford, California.
  • Gabriel E; Division of Oncology, Department of Medicine, Stanford University, Stanford, California.
  • Kurtz DM; Division of Oncology, Department of Medicine, Stanford University, Stanford, California.
  • Khodadoust MS; Division of Oncology, Department of Medicine, Stanford University, Stanford, California.
  • Gupta NK; Division of Oncology, Department of Medicine, Stanford University, Stanford, California.
  • Maeda LS; Division of Oncology, Department of Medicine, Stanford University, Stanford, California.
  • Advani RH; Division of Oncology, Department of Medicine, Stanford University, Stanford, California.
  • Alizadeh AA; Division of Oncology, Department of Medicine, Stanford University, Stanford, California.
  • Levy R; Division of Oncology, Department of Medicine, Stanford University, Stanford, California.
Blood Cancer Discov ; 3(2): 95-102, 2022 Mar 01.
Article en En | MEDLINE | ID: mdl-35015688
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Vacunas contra la COVID-19 / COVID-19 Límite: Humans / Infant Idioma: En Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Vacunas contra la COVID-19 / COVID-19 Límite: Humans / Infant Idioma: En Año: 2022 Tipo del documento: Article